Qube Research & Technologies (QRT)
WST icon

Qube Research & Technologies (QRT)’s West Pharmaceutical WST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,304
Closed -$5.59M – 4169
2026
Q1 		$5.59M Sell
22,304
-73,726
-77% -$18.3M 0.01% 1589
2025
Q4 		$26.4M Buy
+96,030
New +$26.3M 0.03% 774
2025
Q3 		– Sell
-139,819
Closed -$30.6M – 4007
2025
Q2 		$30.6M Buy
+139,819
New +$29.9M 0.03% 672
2024
Q2 		– Sell
-22,712
Closed -$8.99M – 4828
2024
Q1 		$8.99M Sell
22,712
-275,452
-92% -$102M 0.01% 907
2023
Q4 		$105M Buy
298,164
+281,072
+1,644% +$99.5M 0.2% 111
2023
Q3 		$6.41M Buy
17,092
+16,291
+2,034% +$6.3M 0.02% 825
2023
Q2 		$306K Buy
+801
New +$286K ﹤0.01% 1652
2023
Q1 		– Sell
-15,106
Closed -$3.56M – 3092
2022
Q4 		$3.56M Sell
15,106
-57,494
-79% -$13.6M 0.02% 755
2022
Q3 		$17.9M Sell
72,600
-29,922
-29% -$9.12M 0.11% 262
2022
Q2 		$31M Buy
102,522
+69,209
+208% +$22.5M 0.23% 106
2022
Q1 		$13.7M Sell
33,313
-2,224
-6% -$871K 0.12% 230
2021
Q4 		$16.7M Buy
35,537
+27,689
+353% +$11.9M 0.13% 188
2021
Q3 		$3.33M Sell
7,848
-6,746
-46% -$2.84M 0.04% 536
2021
Q2 		$5.24M Buy
14,594
+4,234
+41% +$1.4M 0.06% 399
2021
Q1 		$2.92M Buy
+10,360
New +$2.96M 0.05% 512
2020
Q4 		– Sell
-14,471
Closed -$3.98M – 2257
2020
Q3 		$3.98M Buy
+14,471
New +$3.83M 0.06% 432
2019
Q3 		– Sell
-2,979
Closed -$373K – 469
2019
Q2 		$373K Buy
+2,979
New +$352K 0.09% 216
2018
Q4 		– Sell
-2,403
Closed -$297K – 918
2018
Q3 		$297K Buy
2,403
+1,801
+299% +$202K 0.04% 357
2018
Q2 		$60K Buy
+602
New +$55.4K 0.04% 451

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Qube Research & Technologies (QRT)'s WST Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 22,304 shares — an estimated $5.59M sold.

Qube Research & Technologies (QRT) first reported a position in WST in Q2 2018 and held it in 19 quarters. The position peaked at $105M in Q4 2023. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 22,304 West Pharmaceutical shares in Q2 2026, an estimated $5.59M.
  • Qube Research & Technologies (QRT) first reported a position in West Pharmaceutical in Q2 2018 and held it in 19 quarters.
  • Qube Research & Technologies (QRT)'s West Pharmaceutical position peaked at $105M in Q4 2023.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.